0001140361-15-043569.txt : 20151203
0001140361-15-043569.hdr.sgml : 20151203
20151203163509
ACCESSION NUMBER: 0001140361-15-043569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151201
FILED AS OF DATE: 20151203
DATE AS OF CHANGE: 20151203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY INC
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84003
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dreier Ashley
CENTRAL INDEX KEY: 0001614957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 151267766
MAIL ADDRESS:
STREET 1: 15 W. SCENIC POINTE DR., STE. 100
CITY: DRAPER
STATE: UT
ZIP: 84020
4
1
doc1.xml
FORM 4
X0306
4
2015-12-01
0
0001428336
HEALTHEQUITY INC
HQY
0001614957
Dreier Ashley
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive VP, CTO and CIO
Common Stock
2015-12-01
4
M
0
3125
1.5
A
3125
D
Common Stock
2015-12-01
4
S
0
1725
32.0083
D
1400
D
Common Stock
2015-12-01
4
S
0
1400
32.71
D
0
D
Stock Option (right to buy)
1.5
2015-12-01
4
M
0
3125
0
D
2023-05-09
Common Stock
3125
87500
D
Stock Option (right to buy)
1.5
2023-05-09
Common Stock
100000
100000
D
The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 15, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $32.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 to $32.82, inclusive.
The option becomes exercisable in four equal installments on May 9, 2014, 2015, 2016 and 2017.
As previously reported in the reporting person's Form 3, the option grant had a $2.50 exercise price upon issuance. The $2.50 exercise price was automatically adjusted to $1.50 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
The option is immediately exercisable.
/s/ Ashley Dreier
2015-12-03